Ending Eclampsia, 2018 Women’s group findings in Cross River State suggest that community engagement is a critical model for information sharing and is an adaptable, acceptable model for increasing PE/E prevention and danger sign recognition across Nigeria. Qualitative findings reveal…
Tag Archive for treatment
Drugs for treating severe hypertension in pregnancy: A network meta-analysis and trial sequential analysis of randomized clinical trials
British Journal of Clinical Pharmacology, 2018 This network meta-analysis suggests similar efficacy nifedipine, hydralazine, and labetalol in the treatment of severe hypertension in pregnancy. The above drugs may also be useful in treating hypertension in severe pre-eclampsia. Moderate quality of evidence was observed for direct comparison…
Determinants of pre-eclampsia/eclampsia among women attending delivery services in selected public hospitals of Addis Ababa, Ethiopia: A case control study
BMC Pregnancy and Childbirth, 2017 The study identified protective and risk factors for PE/E. To promptly diagnose and treat pre-eclampsia, health workers need to pay special attention to women with primigravida and multiple pregnancy. Health care providers should also provide nutritional…
Nutrition and pre-eclampsia risk factors in Ethiopia
By Khadijah Alibhai In Ethiopia, 412 women die per 100,000 live births. Most of these deaths are preventable, and 19 percent of them are from hypertensive disorders of pregnancy, including pre-eclampsia and eclampsia (PE/E). Typically, pre-eclampsia is detectable during early…
The effect of loading dose of magnesium sulfate on uterine, umbilical, and fetal middle cerebral arteries Doppler in women with severe preeclampsia: A case control study
Hypertension in Pregnancy, 2016 Intravenous administration of magnesium sulfate in pregnant women with severe pre-eclampsia resulted in a decrease in umbilical artery, uterine artery, and fetal middle cerebral artery Doppler indices and reduced resistance to blood flow.
A comparison between the two methods of magnesium sulfate administration for duration of 12 versus 24 h after delivery in patients with severe preeclampsia
The Journal of Maternal-Fetal & Neonatal Medicine, 2015 The women of the two groups did not have significant difference according to age, BMI, parity and gravidity, gestational age at the time of delivery. Results showed that administration of magnesium sulphate…
Risk factors for pre-eclampsia and eclampsia in Mexico
Ending Eclampsia, 2018 This infographic provides data on risk factors, policies, health system capacity and community perceptions in Mexico-specific data on demographics, health risks, barriers to accessing care, pregnancy-related care, maternal death data, newborn/infant death data, national/provincial policies, and delivery…
Exploring opportunities for preventing and managing pre-eclampsia/eclampsia
Ending Eclampsia, 2018 Results from this study will identify gaps and barriers in the Kenyan health system gaps around PE/E knowledge and attitudes. Researchers aim to enhance PE/E prevention and management, and ANC accessibility/acceptability by sharing and integrating findings with…
Exploring opportunities for preventing and managing pre-eclampsia/eclampsia
Ending Eclampsia, 2018 Analysis of data collected in 2017 is currently ongoing for this study. Findings will be shared in February 2018. Findings will highlight existing barriers and opportunities for PE/E prevention and treatment, and can inform national policies and…
Feasibility of PHC providers prescribing antihypertensive drugs to pregnant women
Ending Eclampsia, 2018 The study will last 12 months and includes 20 to 25 facilities – approximately 50 providers – from two sub-districts, and enrolls 800 pregnant women with hypertension. Researchers anticipate understanding whether it is feasible for PHC providers…
